drugset / Trial / NCT00201461

Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)

NCT00201461 ↗

Phase 2/3 Unknown 900 enrolled NMT Medical
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of the study is to determine whether the STARFlex® septal closure system will safely and effectively prevent a recurrent embolic stroke/transient ischemic attack (TIA) and mortality in patients with a PFO and to demonstrate superiority of the STARFlex® device compared to best medical therapy.

Timeline

Start
2003-06
Primary completion
—
Completion
2010-04

Outcome

Missed primary endpoint

paper closure with a device did not offer a greater benefit than medical therapy alone for the prevention of recurrent stroke or TIA. PMID 22417252 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 325 mg —
Subject Warfarin Small molecule — —